AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Lia Taylor

Examiner Lia Taylor appears to be about average relative to their peer examiners. Their lifetime grant ratio is 46.5%, they average 2.10 office actions per granted patent, and their rejection profile leans toward §103 and elevated §112 usage.

Difficulty vs AU Very Easy
Difficulty vs Group About Average
Difficulty vs TC About Average
Difficulty vs USPTO Very Hard
Average OA / Grant 2.10
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
7 years (2020-2026)
Phone
(571) 272-6336
Predicted Supervisor
Misook Yu
Supervisor Phone
(571) 272-0839
Tech Center
1600 - Biotechnology and Organic
Group
1640 - Immunology

Metrics

Applications Evaluated
215
Granted Applications
100
Non-Granted Applications
115
Avg OA / Grant
2.10
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1641 , 1644
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 46.5% 2.10
Art Unit 28 44.8% 2.26
Group 223 44.8% 1.94
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2020 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2020; examiner may not yet have been active in the available dataset.
2020 3 1 33.3%
2021 26 15 57.7%
2022 30 18 60.0%
2023 43 26 60.5%
2024 35 24 68.6%
2025 57 16 28.1%
2026 21 0 0.0%

100 family-cache-validated grants; 1 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 215 0.0% 8.4% 23.7% 17.7%
2 132 3.8% 15.2% 18.9% 37.9%
3 69 2.9% 7.2% 33.3% 24.6%
4 36 0.0% 11.1% 30.6% 30.6%
5 21 0.0% 4.8% 47.6% 33.3%
6 16 0.0% 12.5% 43.8% 31.3%
7 5 0.0% 0.0% 80.0% 20.0%
8 2 0.0% 0.0% 0.0% 100.0%
9 1 0.0% 0.0% 100.0% 0.0%
10 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2020
1.4%
2021
3.2%
2022
0.0%
2023
2.1%
2024
1.1%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.